| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0006 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |